Literature DB >> 29618513

The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.

Haoming Zhang1, Adam L Yokom2, Shen Cheng3, Min Su4, Paul F Hollenberg3, Daniel R Southworth2, Yoichi Osawa5.   

Abstract

The cytochrome P450 enzyme CYP102A1 from Bacillus megaterium is a highly efficient hydroxylase of fatty acids, and there is a significant interest in using CYP102A1 for biotechnological applications. Here, we used size-exclusion chromatography-multiangle light scattering (SEC-MALS) analysis and negative-stain EM to investigate the molecular architecture of CYP102A1. The SEC-MALS analysis yielded a homogeneous peak with an average molecular mass of 235 ± 5 kDa, consistent with homodimeric CYP102A1. The negative-stain EM of dimeric CYP102A1 revealed four distinct lobes, representing the two heme and two reductase domains. Two of the lobes were in close contact, whereas the other two were often observed apart and at the ends of a U-shaped configuration. The overall dimension of the dimer was ∼130 Å. To determine the identity of the lobes, we FLAG-tagged the N or C terminus of CYP102A1 to visualize additional densities in EM and found that anti-FLAG Fab could bind only the N-tagged P450. Single-particle analysis of this anti-Flag Fab-CYP102A1 complex revealed additional density in the N-terminally tagged heme domains, indicating that the heme domains appear flexible, whereas the reductase domains remain tightly associated. The effects of truncation on CYP102A1 dimerization, identification of cross-linked sites by peptide mapping, and molecular modeling results all were consistent with the dimerization of the reductase domain. We conclude that functional CYP102A1 is a compact globular protein dimerized at its reductase domains, with its heme domains exhibiting multiple conformations that likely contribute to the highly efficient catalysis of CYP102A1.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cytochrome P450; cytochrome P450 BM3; dimerization; electron microscopy (EM); electron transfer; fatty acid hydroxylase; heme domain; protein structure; reductase domain

Mesh:

Substances:

Year:  2018        PMID: 29618513      PMCID: PMC5961045          DOI: 10.1074/jbc.RA117.000600

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  38 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer.

Authors:  Hazel M Girvan; Adrian J Dunford; Rajasekhar Neeli; Idorenyin S Ekanem; Timothy N Waltham; M Gordon Joyce; David Leys; Robin A Curtis; Paul Williams; Karl Fisher; Michael W Voice; Andrew W Munro
Journal:  Arch Biochem Biophys       Date:  2010-09-22       Impact factor: 4.013

3.  Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450.

Authors:  Christopher R Otey; Geethani Bandara; James Lalonde; Katsuyuki Takahashi; Frances H Arnold
Journal:  Biotechnol Bioeng       Date:  2006-02-20       Impact factor: 4.530

4.  [Atomic force microscopy monitoring of temperature dependence of cytochrome BM3 oligomeric state].

Authors:  N S Bukharina; Iu D Ivanov; T O Pleshakova; P A Frantsuzov; N D Ivanova; N V Krokhin; N A Petushkova; A I Archakov
Journal:  Biofizika       Date:  2015 Jan-Feb

5.  Comparison of random mutagenesis and semi-rational designed libraries for improved cytochrome P450 BM3-catalyzed hydroxylation of small alkanes.

Authors:  Mike M Y Chen; Christopher D Snow; Christina L Vizcarra; Stephen L Mayo; Frances H Arnold
Journal:  Protein Eng Des Sel       Date:  2012-02-14       Impact factor: 1.650

6.  The crystal structure of the FAD/NADPH-binding domain of flavocytochrome P450 BM3.

Authors:  Michael G Joyce; Idorenyin S Ekanem; Olivier Roitel; Adrian J Dunford; Rajasekhar Neeli; Hazel M Girvan; George J Baker; Robin A Curtis; Andrew W Munro; David Leys
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

7.  Evidence for conformational dynamics and molecular aggregation in cytochrome P450 102 (BM-3).

Authors:  S D Black; S T Martin
Journal:  Biochemistry       Date:  1994-10-11       Impact factor: 3.162

8.  Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.

Authors:  Christopher F Butler; Caroline Peet; Amy E Mason; Michael W Voice; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2013-07-03       Impact factor: 5.157

9.  RELION: implementation of a Bayesian approach to cryo-EM structure determination.

Authors:  Sjors H W Scheres
Journal:  J Struct Biol       Date:  2012-09-19       Impact factor: 2.867

10.  The architecture of Tetrahymena telomerase holoenzyme.

Authors:  Jiansen Jiang; Edward J Miracco; Kyungah Hong; Barbara Eckert; Henry Chan; Darian D Cash; Bosun Min; Z Hong Zhou; Kathleen Collins; Juli Feigon
Journal:  Nature       Date:  2013-04-03       Impact factor: 49.962

View more
  10 in total

1.  Cryo-EM reveals the architecture of the dimeric cytochrome P450 CYP102A1 enzyme and conformational changes required for redox partner recognition.

Authors:  Min Su; Sumita Chakraborty; Yoichi Osawa; Haoming Zhang
Journal:  J Biol Chem       Date:  2020-01-03       Impact factor: 5.157

2.  Neutron scattering maps the higher-order assembly of NADPH-dependent assimilatory sulfite reductase.

Authors:  Daniel T Murray; Nidhi Walia; Kevin L Weiss; Christopher B Stanley; Peter S Randolph; Gergely Nagy; M Elizabeth Stroupe
Journal:  Biophys J       Date:  2022-04-20       Impact factor: 3.699

3.  Amphipol-facilitated Elucidation of the Functional Tetrameric Complex of Full-length Cytochrome P450 CYP2B4 and NADPH-Cytochrome-P450 Oxidoreductase.

Authors:  Shen Cheng; Zhiyuan Bo; Paul Hollenberg; Yoichi Osawa; Haoming Zhang
Journal:  J Biol Chem       Date:  2021-04-08       Impact factor: 5.157

4.  Structural insight into the electron transfer pathway of a self-sufficient P450 monooxygenase.

Authors:  Lilan Zhang; Zhenzhen Xie; Ziwei Liu; Shuyu Zhou; Lixin Ma; Weidong Liu; Jian-Wen Huang; Tzu-Ping Ko; Xiuqin Li; Yuechan Hu; Jian Min; Xuejing Yu; Rey-Ting Guo; Chun-Chi Chen
Journal:  Nat Commun       Date:  2020-05-29       Impact factor: 14.919

5.  An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase.

Authors:  Goutam Mukherjee; Prajwal P Nandekar; Rebecca C Wade
Journal:  Commun Biol       Date:  2021-01-08

Review 6.  The Biosynthesis of Enzymatically Oxidized Lipids.

Authors:  Ali A Hajeyah; William J Griffiths; Yuqin Wang; Andrew J Finch; Valerie B O'Donnell
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-19       Impact factor: 5.555

7.  Genetic fusion of P450 BM3 and formate dehydrogenase towards self-sufficient biocatalysts with enhanced activity.

Authors:  Arsenij Kokorin; Pavel D Parshin; Patrick J Bakkes; Anastasia A Pometun; Vladimir I Tishkov; Vlada B Urlacher
Journal:  Sci Rep       Date:  2021-11-04       Impact factor: 4.379

Review 8.  Inhibition of CYP2C8 by Acyl Glucuronides of Gemfibrozil and Clopidogrel: Pharmacological Significance, Progress and Challenges.

Authors:  Manish B Shah
Journal:  Biomolecules       Date:  2022-09-01

9.  Characterization of the structure and interactions of P450 BM3 using hybrid mass spectrometry approaches.

Authors:  Laura N Jeffreys; Kamila J Pacholarz; Linus O Johannissen; Hazel M Girvan; Perdita E Barran; Michael W Voice; Andrew W Munro
Journal:  J Biol Chem       Date:  2020-04-17       Impact factor: 5.157

10.  Artificial Fusions between P450 BM3 and an Alcohol Dehydrogenase for Efficient (+)-Nootkatone Production.

Authors:  Arsenij Kokorin; Vlada B Urlacher
Journal:  Chembiochem       Date:  2022-04-06       Impact factor: 3.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.